Liu Wendao, Jia Johnathan, Dai Yulin, Chen Wenhao, Pei Guangsheng, Yan Qiheng, Zhao Zhongming
The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Center for Precision Health, School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Innovation (Camb). 2022 Sep 13;3(5):100289. doi: 10.1016/j.xinn.2022.100289. Epub 2022 Jul 21.
Understanding the molecular mechanisms of coronavirus disease 2019 (COVID-19) pathogenesis and immune response is vital for developing therapies. Single-cell RNA sequencing has been applied to delineate the cellular heterogeneity of the host response toward COVID-19 in multiple tissues and organs. Here, we review the applications and findings from over 80 original COVID-19 single-cell RNA sequencing studies as well as many secondary analysis studies. We describe that single-cell RNA sequencing reveals multiple features of COVID-19 patients with different severity, including cell populations with proportional alteration, COVID-19-induced genes and pathways, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in single cells, and adaptation of immune repertoire. We also collect published single-cell RNA sequencing datasets from original studies. Finally, we discuss the limitations in current studies and perspectives for future advance.
了解2019冠状病毒病(COVID-19)发病机制和免疫反应的分子机制对于开发治疗方法至关重要。单细胞RNA测序已被用于描绘多个组织和器官中宿主对COVID-19反应的细胞异质性。在此,我们回顾了80多项COVID-19单细胞RNA测序原始研究以及许多二次分析研究的应用和发现。我们描述了单细胞RNA测序揭示了不同严重程度COVID-19患者的多个特征,包括比例改变的细胞群体、COVID-19诱导的基因和通路、单细胞中的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染以及免疫库的适应性。我们还收集了原始研究中已发表的单细胞RNA测序数据集。最后,我们讨论了当前研究的局限性和未来进展的前景。